EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Interleukin-15 complex–induced interleukin-10 acts on brain endothelial cells to reduce CD8 T-cell arrest during cerebral malaria

Jacob A Hildebrand, Erin D Lucas, Noah R Daniels, Benjamin D Fisher, Chris J Janse, Kory R Johnson, Caleb Y Kim, Jason S Mitchell, Jules A Sangala, Trevor N Tankersley iD, Brian T Fife, Dorian B McGavern und 2 weitere

The Journal of Immunology · 02.11.2026 · 215 (11)

DOI: 10.1093/jimmun/vkag295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 06.11.2026. Verfasst von Jacob A Hildebrand und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology, University of Minnesota, Minneapolis, MN, United States. Hauptthemen laut MEDLINE: Malaria, Cerebral, CD8-Positive T-Lymphocytes, Interleukin-15, Brain. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral malaria (CM) is a life-threatening complication of Plasmodium infection driven in part by an overwhelming inflammatory response. No clinical therapies are approved that specifically prevent immunopathology during CM. In experimental cerebral malaria (ECM), vascular endothelial cells in the mouse brain cross-present malaria antigen and upregulate adhesion molecules in response to inflammation. This causes CD8 T-cell arrest, activation, and lethal disruption of the blood-brain barrier. We previously reported that treatment with IL-15 cytokine complex (IL-15C) prevents ECM by inducing natural killer (NK) cell secretion of IL-10. To further uncover the mechanisms underlying this immunotherapy, OT-I T cells were transferred into mice, followed by infection with ovalbumin-expressing Plasmodium berghei. Using intravital microscopy, we observed major areas of OT-I arrest within the brains of untreated mice experiencing ECM. IL-15C treatment reduced the number of arresting OT-I T cells, coinciding with an increased mean velocity when compared to untreated mice. To identify the target of NK cell–secreted IL-10, we used conditional knockouts of IL-10Rα and found that protection from ECM occurs through IL-10Rα on endothelial cells and not CD8 T cells. Coinciding with this, IL-15C reduced the expression of adhesion molecules, selectins, and MHC-I on brain endothelial cells. In summary, our studies support the mechanism that IL-15C treatment reduces the number of arrested CD8 T cells along the cerebral vasculature by modulating endothelial cells to prevent ECM. These insights demonstrate the potential for treatments that reduce T-cell arrest to improve outcomes of human CM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, CerebralCD8-Positive T-LymphocytesInterleukin-15BrainInterleukin-10Plasmodium bergheiEndothelial CellsAnimalsMiceKiller Cells, NaturalMice, Inbred C57BLBlood-Brain BarrierDisease Models, Animal

Stichwörter der Autor:innen

PlasmodiumCD8 T cellsT-cell arrestcerebral malariaintravital microscopy

Substanzen

Interleukin-15Interleukin-10

Autor:innen und Institutionen

  • Center for Immunology, University of Minnesota, Minneapolis, MN, United States.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States.
  • Leiden University Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Bioinformatics Core, Division of Intramural Research, National Institutes of Health, Bethesda, MD, United States.
  • Division of Rheumatic and Autoimmune Diseases, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
  • Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

ORCID-Profile: Trevor N Tankersley, Sara E Hamilton

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Hildebrand, J. A., Lucas, E. D., Daniels, N. R., Fisher, B. D., Janse, C. J., Johnson, K. R., Kim, C. Y., Mitchell, J. S., Sangala, J. A., Tankersley, T. N., Fife, B. T., McGavern, D. B., Hart, G. T., & Hamilton, S. E. (2026). Interleukin-15 complex–induced interleukin-10 acts on brain endothelial cells to reduce CD8 T-cell arrest during cerebral malaria. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag295

Vancouver

Hildebrand JA, Lucas ED, Daniels NR, Fisher BD, Janse CJ, Johnson KR, et al. Interleukin-15 complex–induced interleukin-10 acts on brain endothelial cells to reduce CD8 T-cell arrest during cerebral malaria. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag295

BibTeX
@article{Hildebrand2026,
  author = {Hildebrand, Jacob A and Lucas, Erin D and Daniels, Noah R and Fisher, Benjamin D and Janse, Chris J and Johnson, Kory R and Kim, Caleb Y and Mitchell, Jason S and Sangala, Jules A and Tankersley, Trevor N and Fife, Brian T and McGavern, Dorian B and Hart, Geoffrey T and Hamilton, Sara E},
  title = {Interleukin-15 complex–induced interleukin-10 acts on brain endothelial cells to reduce CD8 T-cell arrest during cerebral malaria},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {11},
  doi = {10.1093/jimmun/vkag295}
}
Kostenlos starten →